Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVRNASDAQ:LUCDNASDAQ:OBIONASDAQ:POCI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVRAnteris Technologies Global$4.51-4.9%$3.87$2.34▼$8.79$162.64MN/A206,550 shs105,572 shsLUCDLucid Diagnostics$1.52$1.35$0.68▼$1.80$164.45M1.28540,164 shs881,456 shsOBIOOrchestra BioMed$2.83-4.1%$2.98$2.37▼$8.87$108.43M0.67165,357 shs212,630 shsPOCIPrecision Optics$4.52-3.0%$4.28$3.47▼$6.90$34.65M0.2414,794 shs11,199 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVRAnteris Technologies Global-4.85%+39.63%-18.15%-35.57%+450,999,900.00%LUCDLucid Diagnostics0.00%+14.29%+20.63%+2.70%+69.28%OBIOOrchestra BioMed-4.07%+3.66%+11.86%-39.66%-59.57%POCIPrecision Optics-0.88%+3.20%+5.48%-1.31%-34.49%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVRAnteris Technologies GlobalN/AN/AN/AN/AN/AN/AN/AN/ALUCDLucid Diagnostics2.7923 of 5 stars3.63.00.00.03.11.70.6OBIOOrchestra BioMed3.0843 of 5 stars4.64.00.00.02.20.80.0POCIPrecision Optics0.3117 of 5 stars0.03.00.00.01.90.80.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVRAnteris Technologies Global 3.00Buy$16.50265.85% UpsideLUCDLucid Diagnostics 3.20Buy$3.50130.26% UpsideOBIOOrchestra BioMed 3.20Buy$14.20401.77% UpsidePOCIPrecision Optics 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest POCI, LUCD, OBIO, and AVR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2025LUCDLucid DiagnosticsCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$2.00 ➝ $2.005/14/2025LUCDLucid DiagnosticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.00 ➝ $3.005/13/2025OBIOOrchestra BioMedChardan CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$20.00 ➝ $20.005/5/2025OBIOOrchestra BioMedBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$16.00 ➝ $12.004/23/2025OBIOOrchestra BioMedHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy4/22/2025OBIOOrchestra BioMedChardan CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$20.00 ➝ $20.004/21/2025LUCDLucid DiagnosticsAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$7.00 ➝ $7.504/11/2025LUCDLucid DiagnosticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.00 ➝ $3.004/4/2025OBIOOrchestra BioMedHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$14.00 ➝ $12.004/3/2025OBIOOrchestra BioMedB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/1/2025OBIOOrchestra BioMedChardan CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$20.00 ➝ $20.00(Data available from 5/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVRAnteris Technologies Global$2.71M59.99N/AN/AN/A∞LUCDLucid Diagnostics$4.17M39.41N/AN/A($0.47) per share-3.23OBIOOrchestra BioMed$2.89M37.57N/AN/A$1.90 per share1.49POCIPrecision Optics$17.63M1.97N/AN/A$1.49 per share3.03Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVRAnteris Technologies GlobalN/AN/A0.00N/AN/AN/AN/AN/AN/ALUCDLucid Diagnostics-$52.67M-$1.34N/AN/AN/A-1,069.87%N/A-123.54%8/11/2025 (Estimated)OBIOOrchestra BioMed-$49.12M-$1.78N/AN/AN/A-2,179.33%-107.04%-70.88%N/APOCIPrecision Optics-$2.95M-$0.89N/A∞N/A-21.46%-39.17%-22.93%N/ALatest POCI, LUCD, OBIO, and AVR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q3 2025POCIPrecision OpticsN/A-$0.30N/A-$0.30N/A$4.19 million5/13/2025Q1 2025AVRAnteris Technologies GlobalN/A-$0.61N/A-$0.61N/AN/A5/12/2025Q1 2025OBIOOrchestra BioMed-$0.46-$0.49-$0.03-$0.49$0.39 million$0.87 million3/31/2025Q4 2024OBIOOrchestra BioMed-$0.43-$0.43N/A-$0.43$0.79 million$0.25 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVRAnteris Technologies GlobalN/AN/AN/AN/AN/ALUCDLucid DiagnosticsN/AN/AN/AN/AN/AOBIOOrchestra BioMedN/AN/AN/AN/AN/APOCIPrecision OpticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVRAnteris Technologies GlobalN/AN/AN/ALUCDLucid DiagnosticsN/A1.181.14OBIOOrchestra BioMedN/A4.234.21POCIPrecision Optics0.171.220.62Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVRAnteris Technologies GlobalN/ALUCDLucid Diagnostics74.01%OBIOOrchestra BioMed53.55%POCIPrecision Optics13.71%Insider OwnershipCompanyInsider OwnershipAVRAnteris Technologies GlobalN/ALUCDLucid Diagnostics6.80%OBIOOrchestra BioMed8.10%POCIPrecision Optics12.99%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVRAnteris Technologies Global13836.06 millionN/AN/ALUCDLucid Diagnostics70108.19 million54.12 millionNo DataOBIOOrchestra BioMed438.31 million35.47 millionNot OptionablePOCIPrecision Optics807.67 million5.33 millionNot OptionablePOCI, LUCD, OBIO, and AVR HeadlinesRecent News About These CompaniesPrecision Optics Co., Inc. (NASDAQ:POCI) Sees Large Growth in Short InterestMay 29 at 4:01 AM | americanbankingnews.comPrecision Optics to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025May 27 at 4:15 PM | globenewswire.comPrecision Optics reports annual meeting resultsMay 25, 2025 | investing.comPrecision Optics Corporation: Precision Optics Reports Third Quarter Fiscal Year 2025 Financial ResultsMay 16, 2025 | finanznachrichten.dePrecision Optics Corporation, Inc. (POCI) Q1 2025 Earnings Conference Call TranscriptMay 15, 2025 | seekingalpha.comPrecision Optics Reports Third Quarter Fiscal Year 2025 Financial ResultsMay 15, 2025 | globenewswire.comPrecision Optics Market Global Forecast Report to 2030: Cumulative Impact of United States TariffsMay 14, 2025 | globenewswire.comPrecision Optics Schedules Third Quarter of Fiscal Year 2025 Conference Call for May 15, 2025May 8, 2025 | globenewswire.comPrecision Optics to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025April 21, 2025 | globenewswire.comPrecision Optics Signs Major Aerospace Deal, Expands Backlog To $6.6M With New OrdersApril 5, 2025 | nasdaq.comPrecision Optics enters into main purchase agreement with aerospace customerApril 4, 2025 | markets.businessinsider.comPrecision Optics to Participate in the Lytham [...]March 27, 2025 | aktiencheck.dePrecision Optics to Participate in the Lytham Partners 2025 Industrials & Basic Materials Investor Summit on April 1, 2025March 27, 2025 | globenewswire.comPrecision Optics Appoints Joseph P. Pellegrino, Jr. to Board of DirectorsMarch 20, 2025 | globenewswire.comPrecision Optics Appoints Buell Duncan to Board of Directors; Dr. Richard Miles Retires from BoardMarch 4, 2025 | globenewswire.comPrecision Optics Announces Closing of $5.1 Million Offering of Common Stock to Fund Business ExpansionFebruary 24, 2025 | globenewswire.comPrecision Optics prices 1.27M shares at $4.00 in registered direct offeringFebruary 20, 2025 | markets.businessinsider.comPrecision Optics Announces Pricing of $5.1 Million Offering of Common Stock to Fund Business ExpansionFebruary 20, 2025 | finance.yahoo.comEarnings call transcript: Precision Optics Q2 FY2025 shows revenue dropFebruary 13, 2025 | msn.comPrecision Optics Reports Second Quarter Fiscal Year 2025 Financial ResultsFebruary 13, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePOCI, LUCD, OBIO, and AVR Company DescriptionsAnteris Technologies Global NASDAQ:AVR$4.51 -0.23 (-4.85%) As of 05/29/2025 04:00 PM EasternAnteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.Lucid Diagnostics NASDAQ:LUCD$1.52 0.00 (0.00%) Closing price 05/29/2025 04:00 PM EasternExtended Trading$1.51 -0.01 (-0.66%) As of 05/29/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.Orchestra BioMed NASDAQ:OBIO$2.83 -0.12 (-4.07%) Closing price 05/29/2025 04:00 PM EasternExtended Trading$2.89 +0.06 (+1.98%) As of 05/29/2025 05:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.Precision Optics NASDAQ:POCI$4.52 -0.14 (-3.00%) As of 05/29/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hormel Stock Near Lows, But Tariff Relief Could Boost Outlook Salesforce’s Stock Price Presents an Opportunity to Buy NVIDIA Will Set a New High Soon, Then Keep Rallying, Here’s Why Goodyear Stock Surges 28% in 2025: Is More Growth Ahead? Intel's Loss Is Broadcom's Gain as AVGO Dominates Networking Target's Big Bet: Is It a Cheap Stock or a Value Trap? Dividend Investors Looking for an Edge? 3 Stocks Insiders Bought Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.